Promis Neurosciences Inc (PMN)

Mar 10, 2026

Sentiment Recap: Can ProMIS Neurosciences Inc. continue delivering strong returns2026 Earnings Impact & Weekly Chart Analysis and Guides - baoquankhu1.vn

Mar 10, 2026

Mar 10, 2026

Promis Neurosciences (NASDAQ:PMN) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Mar 10, 2026

Mar 09, 2026

Published on: 2026-03-10 05:13:34 - baoquankhu1.vn

Mar 09, 2026

Mar 07, 2026

Trade Report: Can ProMIS Neurosciences Inc continue delivering strong returnsJuly 2025 Fed Impact & AI Powered Buy/Sell Recommendations - baoquankhu1.vn

Mar 07, 2026

Mar 06, 2026

Eugene Williams Increases Stake in ProMIS Neurosciences Inc with Recent Share Purchase - GuruFocus

Mar 06, 2026

Mar 05, 2026

Published on: 2026-03-05 21:52:27 - baoquankhu1.vn

Mar 05, 2026

Mar 04, 2026

Eugene Williams Increases Stake in ProMIS Neurosciences Inc - GuruFocus

Mar 04, 2026

Mar 04, 2026

Promis Neurosciences (NASDAQ:PMN) Director Eugene Williams Buys 2,000 Shares - MarketBeat

Mar 04, 2026

Mar 04, 2026

Eugene Williams Acquires 1,000 Shares of Promis Neurosciences (NASDAQ:PMN) Stock - MarketBeat

Mar 04, 2026

Mar 02, 2026

ProMIS Neurosciences, Inc. (PMN.TO) Competitors - Meyka

Mar 02, 2026

Feb 27, 2026

PMN Stock Price and Chart — NASDAQ:PMN - TradingView

Feb 27, 2026

Feb 26, 2026

ProMIS Neurosciences : PMN - 24/7 Wall St.

Feb 26, 2026

Feb 25, 2026

Ally Bridge entities disclose ProMIS (PMN) shares and warrant terms - Stock Titan

Feb 25, 2026

Feb 25, 2026

PMN PE Ratio & Valuation, Is PMN Overvalued - Intellectia AI

Feb 25, 2026

Feb 24, 2026

Can ADMA Biologics Inc deliver consistent EPS growthJuly 2025 Breakouts & Short-Term Trading Alerts - baoquankhu1.vn

Feb 24, 2026

Feb 23, 2026

Insider Buying: Johanne Kaplan Acquires Shares of ProMIS Neurosc - GuruFocus

Feb 23, 2026

Feb 23, 2026

Insider buy: ProMIS Neurosciences (PMN) CDO acquires 1,629 shares at $15.35 - Stock Titan

Feb 23, 2026

Feb 20, 2026

Final Results - ADVFN

Feb 20, 2026

Feb 19, 2026

What to expect from Gossamer Bio’s late-stage lung disease study - statnews.com

Feb 19, 2026

Feb 16, 2026

ProMIS Neurosciences CEO touts “watershed year” as PMN310 Alzheimer’s Phase 1b data nears - Defense World

Feb 16, 2026

Feb 15, 2026

Is ProMIS Neurosciences Inc. stock positioned well for digital economyWeekly Trend Recap & Smart Swing Trading Techniques - mfd.ru

Feb 15, 2026

Feb 14, 2026

Promis Neurosciences (NASDAQ:PMN) Cut to “Strong Sell” at Wall Street Zen - Defense World

Feb 14, 2026

Feb 14, 2026

PMN Should I Buy - Intellectia AI

Feb 14, 2026

Feb 11, 2026

SPHERA FUNDS MANAGEMENT LTD. Acquires Additional Shares in ProMIS Neurosciences Inc. - GuruFocus

Feb 11, 2026

Feb 11, 2026

ProMIS Neurosciences: Phase 1b Alzheimer's trial fully enrolled and financed, with pivotal data expected in 2026 - TradingView

Feb 11, 2026

Feb 11, 2026

Is ProMIS Neurosciences Inc. (23J0) stock a safe buy pre earningsJobs Report & Weekly Breakout Stock Alerts - mfd.ru

Feb 11, 2026

Feb 07, 2026

Guggenheim Remains a Buy on ProMIS Neurosciences (PMN) - The Globe and Mail

Feb 07, 2026

Feb 06, 2026

Insider Stock Purchases: February 06, 2026 - Quiver Quantitative

Feb 06, 2026

Feb 06, 2026

ProMIS Neurosciences (PMN) Rating Maintained but Price Target Sl - GuruFocus

Feb 06, 2026

Feb 05, 2026

ProMIS Neurosciences to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - The Manila Times

Feb 05, 2026

Feb 03, 2026

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Feb 03, 2026

Feb 03, 2026

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Feb 03, 2026

Feb 02, 2026

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Feb 02, 2026

Feb 02, 2026

Profit Review: Can ProMIS Neurosciences Inc. continue delivering strong returnsJuly 2025 Trade Ideas & AI Forecasted Entry/Exit Points - baoquankhu1.vn

Feb 02, 2026

Feb 02, 2026

Promis Neurosciences (NASDAQ:PMN) Short Interest Down 14.8% in January - Defense World

Feb 02, 2026

Feb 01, 2026

ProMIS Neurosciences, Inc. announced that it expects to receive $75.464029 million in funding from a group of investors - marketscreener.com

Feb 01, 2026

Jan 31, 2026

ProMIS Neurosciences Announces $75 Million PIPE Financing - The Globe and Mail

Jan 31, 2026

Jan 30, 2026

ProMIS Neurosciences raises $175 million in PIPE financing By Investing.com - Investing.com South Africa

Jan 30, 2026

Jan 30, 2026

ProMIS Neurosciences Inc. (PMN) stock: surges 34% after $175M PIPE financing deal - parameter.io

Jan 30, 2026

Jan 30, 2026

ProMIS Neurosciences Secures $175 Mln In Private Financing - Nasdaq

Jan 30, 2026

Jan 30, 2026

ProMIS Neurosciences Stock Fluctuates Amid Market Developments - timothysykes.com

Jan 30, 2026

Jan 30, 2026

ProMIS Neurosciences Signs Multiple Material Agreements - TradingView

Jan 30, 2026

Jan 30, 2026

ProMIS Neurosciences raises $175 million in PIPE financing - Investing.com

Jan 30, 2026

Jan 30, 2026

ProMIS Neurosciences stock soars after $175 million private placement By Investing.com - Investing.com South Africa

Jan 30, 2026

Jan 30, 2026

ProMIS Neurosciences Secures $175 Million in PIPE Financing to Extend Cash Runway and Support Alzheimer’s Disease Clinical Study - Quiver Quantitative

Jan 30, 2026

Jan 30, 2026

ProMIS Neurosciences stock soars after $175 million private placement - Investing.com

Jan 30, 2026

Jan 30, 2026

ProMIS Neurosciences Announces Up to $175 Million Private Placement Financing - The Manila Times

Jan 30, 2026

Jan 30, 2026

ProMIS lines up up to $175M to extend runway into 2028, fund Alzheimer’s trial - stocktitan.net

Jan 30, 2026